Clostridium difficile -associated disease in human stem cell transplant recipients : coming epidemic or false alarm?
400 cGy TBI with fludarabine for reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation
Feasibility of conditioning with thymoglobulin and reduced intensity TBI to reduce acute GVHD in recipients of allogeneic SCT
G-CSF-stimulated BM progenitor cells supplement suboptimal peripheral blood hematopoietic progenitor cell collections for auto transplantation
The harvest and use of autologous back-up grafts for graft failure or severe GVHD after allogeneic hematopoietic stem cell transplantation : a survey of the European Group for Blood and Marrow Transplantation
The syndrome of inappropriate secretion of antidiuretic hormone associated with SCT : clinical differences following SCT using cord blood and BM/peripheral blood
BM-derived cells randomly contribute to neoplastic and non-neoplastic epithelial tissues at low rates
Efficacy of imatinib mesylate in the treatment of refractory sclerodermatous chronic GVHD
Myeloablative chemotherapy with autologous stem cell rescue for Ewing sarcoma
Myeloablative chemotherapy with autologous stem cell rescue for Ewing sarcoma
Sirolimus in unmanipulated haploidentical cell transplantation
Plasma exchange after hematopoietic stem cell transplantation in multiple myeloma to reduce renal insufficiency
Using reduced intensity conditioning and HLA-identical sibling donors, antithymocyte globulin increases the risk of relapse, which can be overcome by a high stem cell dose